Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 88 publications
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 study.
Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026
CAR19 therapy drives expansion of clonal hematopoiesis and associated cytopenias.
Journal: Research square
Published: November 24, 2025
Superior Chronic Graft-versus-Host Disease-Free Survival with Post-Transplant Cyclophosphamide Relative to Tacrolimus/Methotrexate in Myeloablative HLA-Matched Allogeneic Hematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: November 18, 2025
A systematic literature review and bayesian meta-analysis of oral vancomycin primary prophylaxis for Clostridioides difficile infection in stem cell transplant patients.
Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE
Published: July 14, 2025
Exploring Perspectives on Feasibility, Challenges, and Support Needs for Chlorhexidine Gluconate (CHG) Bathing in the Outpatient Setting for Hematopoietic Cell Transplant Recipients: A Qualitative Study.
Journal: Transplantation and cellular therapy
Published: June 27, 2025
The Impact of Anti-CD38 Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients With Newly Diagnosed Multiple Myeloma (NDMM) Referred From Community and Academic Oncology Practices: Single Center, Real World Data 2021-2024.
Journal: Transplantation and cellular therapy
Published: June 16, 2025
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.
Journal: medRxiv : the preprint server for health sciences
Published: March 10, 2025
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.
Journal: Blood advances
Published: January 21, 2025
Omidubicel-onlv Transplantation for Hematologic Malignancies: Results of a Multicenter Expanded Access Program.
Journal: Transplantation and cellular therapy
Published: January 17, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 03, 2025
Accurate prediction of absolute prokaryotic abundance from DNA concentration.
Journal: Cell reports methods
Published: November 02, 2024
Belumosudil combination therapy for chronic graft-versus-host-disease in real-world clinical practice.
Journal: Bone marrow transplantation
Published: September 04, 2024
Last Updated: 09/26/2026